SV

Street Verdict

Analyst Scorecard

ASTERDM · NSE

Aster DM Quality Care Limited

₹779.3

+5.41% (+₹40)

Prev. close

₹739.3

Volume

26,65,994

Delivery %

51.0%

As of

20 Nov 2026

Price history

₹779.3-₹38.7 (-4.73%) · 3M
18 Aug 2026 → 20 Nov 2026
65070075080018 Aug09 Sept06 Oct29 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

Analysts lean bullish

2 analyst stances · last 90 days · one per analyst

Trackable

2 · 2 bull / 0 neutral / 0 bear

Long-Horizon

none in range

Commentary

none in range

Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded

Bullish 100% (2)Neutral 0% (0)Bearish 0% (0)
Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions
Market commentary · 3 · levels, conditionals, previews, macro & hedged views — context, not graded
CallAnalystInstrumentVerdictActions

Fundamentals

About Aster DM Quality Care Limited

Aster DM Quality Care Limited operates as an integrated healthcare provider in India. The company operates through Hospitals & Clinics, Labs, Wholesale Pharmacies, and Others segments. It offers comprehensive healthcare services including primary, secondary, tertiary and quaternary care in various specialty areas, including multi-specialty, cardiac sciences, OP pharmacy, anaesthesiology and others, neuro sciences, oncology, gastroenterology and integrated liver care, nephrology and urology, orthopaedics, women's health, and child adolescent health areas. The company also operates hospitals and clinics; wholesale pharmacies and optical outlets; and diagnostic labs. In addition, it provides healthcare consultancy and others services; and digital health platforms. The company offers its services and products under Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH brands. Aster DM Quality Care Limited was formerly known as Aster DM Healthcare Limited and changed its name to Aster DM Quality Care Limited in July 2026. The company was founded in 1987 and is based in Bengaluru, India.

Details

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Mr. Varun Khanna

Headquarters

Bengaluru

Employees

15,773

Key stats

Market cap

₹62,649.32 Cr

P/E ratio (TTM)

116.6

Dividend yield

0.44%

EPS (TTM)

₹6.17

Beta (1Y · daily vs NIFTY 50)

0.41

Beta (5Y · monthly vs NIFTY 50)

0.85

Shares float

34.62 Cr

EPS · quarter ended Jun 2026

₹0.31

Financial Performance

01 · Financials

0 Cr5000 Cr10000 Cr15000 Cr₹0%50%100%150%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

050100150₹FY21FY22FY23FY24FY25FY26

03 · Dividend Profile

050100150₹-100%-50%0%50%23 Apr 2422 Aug 2410 Feb 2528 Aug 2502 Apr 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based

-100%-50%0%50%FY21FY22FY23FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

0 Cr5000 Cr10000 Cr15000 Cr20000 Cr₹0×0.5×1×1.5×FY21FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

0 Cr5000 Cr10000 Cr15000 Cr20000 Cr₹FY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

-5000 Cr0 Cr5000 Cr10000 Cr₹FY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss — as filed

Annual

Line itemFY21FY22FY24FY25
₹8,456.87 Cr₹9,667.63 Cr₹3,451.22 Cr₹3,746.58 Cr
Profit before share of profit of equity accounted investees and tax
₹201.53 Cr₹636.31 Cr₹272.53 Cr₹540.11 Cr
Share of loss of equity accounted investees
₹3.52 Cr₹54.00 L₹-11.34 Cr₹-18.91 Cr
Exceptional Items
———₹-50.14 Cr
Profit before tax
₹205.05 Cr₹636.85 Cr₹261.19 Cr₹471.06 Cr
Current tax
₹21.66 Cr₹45.54 Cr₹32.40 Cr₹125.73 Cr
Current tax for earlier years
—₹-1.73 Cr——
Deferred tax
₹5.56 Cr₹-8.01 Cr₹24.11 Cr₹8.64 Cr
Total Tax expense
₹27.22 Cr₹35.80 Cr₹56.51 Cr₹134.37 Cr
Profit for the year from continuing operations
——₹204.68 Cr₹336.69 Cr
(a) Profit/ (loss) before Tax from discontinued operations
——₹69.11 Cr₹-76.89 Cr
(b) Tax expense of discontinued operations
——₹62.23 Cr—
(c) Gain on disposal of business operations
———₹5,148.09 Cr
Profit after tax from discontinued operations
——₹6.88 Cr₹5,071.20 Cr
Profit for the year
₹177.83 Cr₹601.05 Cr₹211.56 Cr₹5,407.89 Cr
Remeasurement of net defined benefit liability
₹-13.10 Cr₹43.88 Cr₹13.89 Cr₹-3.09 Cr
Income tax on items that will not be reclassified subsequently to profit or loss
₹4.00 L₹-90.00 L₹-1.48 Cr₹79.00 L
Exchange difference in translating financial statements of foreign operations
₹-36.65 Cr₹73.27 Cr₹44.22 Cr₹25.00 L
Income tax on items that will be reclassified subsequently to profit or loss
—₹-22.80 Cr₹-10.21 Cr₹-6.00 L
Other comprehensive income, net of taxes
—₹93.45 Cr——
Total other comprehensive income/ (loss), net of taxes
——₹46.42 Cr₹-2.11 Cr
Total comprehensive income for the year
₹128.12 Cr₹694.50 Cr₹257.98 Cr₹5,405.78 Cr
₹177.83 Cr₹601.05 Cr₹211.56 Cr₹5,407.89 Cr
Owners of the Company
₹147.74 Cr₹525.99 Cr₹129.28 Cr₹5,377.83 Cr
Non-controlling interests
₹30.09 Cr₹75.06 Cr₹82.28 Cr₹30.06 Cr
Owners of the Company
₹-43.79 Cr₹82.66 Cr₹42.61 Cr₹-2.04 Cr
Non-controlling interests
₹-5.92 Cr₹10.79 Cr₹3.81 Cr₹-7.00 L
Other comprehensive income for the year
₹-49.71 Cr₹93.45 Cr——
Other comprehensive income/ (loss) for the year
₹-49.71 Cr—₹46.42 Cr₹-2.11 Cr
₹128.12 Cr₹694.50 Cr₹257.98 Cr₹5,405.78 Cr
Owners of the Company
₹103.95 Cr₹608.65 Cr₹171.89 Cr₹5,375.79 Cr
Non-controlling interests
₹24.17 Cr₹85.85 Cr₹86.09 Cr₹29.99 Cr
Basic
2.9710.583.606.16
Diluted
2.9710.573.606.15
Basic
——₹-1₹101.82
Diluted
——₹-1₹101.7
Basic
——₹2.6₹107.98
Diluted
——₹2.6₹107.85

The company’s own captions, order and figures from its annual reports. A dash means the company printed no figure on that line that year. Each year is read from the latest annual report that carries it and was checked against the headline total shown elsewhere on this page.

All years: consolidated statements.

09 · Balance Sheet — as filed

Annual

Line itemFY21FY22FY23FY24FY25
₹8,014.45 Cr₹8,449.78 Cr₹9,959.64 Cr₹3,826.01 Cr₹4,704.91 Cr
Inventories
₹848.99 Cr₹1,025.68 Cr₹1,305.62 Cr₹110.52 Cr₹92.35 Cr
Investments
₹24.13 Cr₹6.64 Cr₹11.25 Cr₹3.30 Cr₹1.42 Cr
Trade receivables
₹2,019.00 Cr₹2,020.52 Cr₹2,336.31 Cr₹233.35 Cr₹257.81 Cr
Cash and cash equivalents
₹258.09 Cr₹343.37 Cr₹378.53 Cr₹82.23 Cr₹164.59 Cr
Other bank balances
₹23.27 Cr₹36.24 Cr———
Bank balances other than cash and cash equivalents above
——₹50.03 Cr₹30.42 Cr₹1,215.41 Cr
Other financial assets
₹112.93 Cr₹168.15 Cr₹188.83 Cr₹39.91 Cr₹116.19 Cr
Other current assets
₹342.60 Cr₹495.86 Cr₹650.99 Cr₹65.28 Cr₹53.70 Cr
Assets classified as held for sale
————₹13,600.29 Cr
Total current assets
₹3,629.01 Cr₹4,096.46 Cr₹4,921.56 Cr₹14,165.30 Cr₹1,901.47 Cr
Total assets
₹11,643.46 Cr₹12,546.24 Cr₹14,881.20 Cr₹17,991.31 Cr₹6,606.38 Cr
₹3,834.12 Cr₹4,482.62 Cr₹4,860.46 Cr₹5,030.11 Cr₹3,651.45 Cr
——₹4,448.07 Cr₹4,559.79 Cr₹3,428.07 Cr
Non-controlling interests
₹461.66 Cr₹529.21 Cr₹412.39 Cr₹470.32 Cr₹223.38 Cr
Borrowings
₹1,754.80 Cr₹1,466.40 Cr₹1,312.30 Cr₹446.08 Cr₹483.71 Cr
Lease liabilities
₹2,274.91 Cr₹2,472.92 Cr₹3,154.41 Cr₹690.40 Cr₹1,345.59 Cr
Other financial liabilities
₹42.55 Cr₹11.66 Cr₹216.49 Cr₹206.62 Cr₹5.95 Cr
Provisions
₹358.63 Cr₹358.94 Cr₹407.12 Cr₹33.11 Cr₹41.78 Cr
Deferred tax liabilities
₹152.59 Cr₹168.93 Cr₹238.06 Cr₹247.63 Cr₹146.12 Cr
Other non-current liabilities
₹30.24 Cr₹26.19 Cr₹37.08 Cr₹49.10 Cr₹52.57 Cr
Total non-current liabilities
₹4,613.72 Cr₹4,505.04 Cr₹5,365.46 Cr₹1,672.94 Cr₹2,075.72 Cr
Borrowings
₹554.27 Cr₹725.76 Cr₹975.18 Cr₹223.24 Cr₹158.47 Cr
Lease liabilities
₹219.67 Cr₹242.05 Cr₹258.41 Cr₹24.03 Cr₹30.00 Cr
Total outstanding dues of micro and small enterprises
₹5.20 Cr₹14.43 Cr₹15.58 Cr₹16.37 Cr₹19.46 Cr
Total outstanding dues of creditors other than micro and small enterprises
₹2,022.14 Cr₹2,103.66 Cr₹2,972.19 Cr₹442.33 Cr₹406.74 Cr
₹3,195.62 Cr₹3,558.58 Cr₹4,655.28 Cr₹11,288.26 Cr₹879.21 Cr
Total equity and liabilities
₹11,643.46 Cr₹12,546.24 Cr₹14,881.20 Cr₹17,991.31 Cr₹6,606.38 Cr

The company’s own captions, order and figures from its annual reports. A dash means the company printed no figure on that line that year. Each year is read from the latest annual report that carries it and was checked against the headline total shown elsewhere on this page.

All years: consolidated statements.

10 · Cash Flow Statement — as filed

Annual

Line itemFY21FY22FY23FY24FY25
₹1,569.12 Cr₹1,314.04 Cr₹1,833.98 Cr₹157.81 Cr₹425.05 Cr
———₹-884.65 Cr₹6,014.87 Cr
₹-330.30 Cr₹-570.48 Cr₹-971.88 Cr——
Net cash generated from /(used in) financing activities (C)
₹-1,116.13 Cr₹-686.00 Cr₹-817.39 Cr₹1,052.83 Cr₹-6,357.81 Cr
Net increase in cash and cash equivalents (A+B+C)
₹122.69 Cr₹57.56 Cr₹44.71 Cr₹325.99 Cr₹82.11 Cr
Cash and cash equivalents at the beginning of the year
₹114.65 Cr₹234.55 Cr₹299.33 Cr₹365.07 Cr₹82.23 Cr
Effect of exchange rate changes on cash and cash equivalents
₹-2.79 Cr₹7.22 Cr₹21.03 Cr₹6.40 Cr₹25.00 L
Cash and cash equivalents at the end of the year*
₹234.55 Cr₹299.33 Cr₹365.07 Cr₹697.46 Cr₹164.59 Cr

The company’s own captions, order and figures from its annual reports. A dash means the company printed no figure on that line that year. Each year is read from the latest annual report that carries it and was checked against the headline total shown elsewhere on this page.

All years: consolidated statements.

11 · Shareholding Pattern

NSE, quarterly

Line itemSep 21Dec 21Mar 22Jun 22–Sep 22(2Q)Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Apr 25Jun 25Sep 25–Mar 26(3Q)Jun 26Jul 26
Promoter37.88%37.88%37.88%37.88%37.88%41.88%41.88%41.88%41.88%41.88%41.88%41.88%41.88%41.89%40.38%40.39%40.39%40.39%53.72%
Public61.64%61.65%61.66%61.67%61.67%57.69%57.70%57.70%57.75%57.77%57.80%57.82%57.84%57.85%59.37%59.36%59.38%59.61%46.28%
Employee trusts0.48%0.47%0.46%0.45%0.44%0.43%0.42%0.41%0.37%0.35%0.32%0.30%0.28%0.26%0.25%0.25%0.23%0.00%0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.25 L Cr₹1,769.938.85.0913.7%0.06+11.9%+3.7%
Divi's Laboratories Limited₹2.66 L Cr₹10,037.590.815.8515.3%0.00+12.3%+47.5%
Torrent Pharmaceuticals Limited₹1.79 L Cr₹4,738.579.421.3125.8%1.79+21.5%+32.5%
Laurus Labs Limited₹1.27 L Cr₹2,34894.823.9416.8%0.48+22.0%+146.2%
Apollo Hospitals Enterprise Limited₹1.23 L Cr₹8,599.558.812.9520.5%0.90+15.7%+10.1%
Zydus Lifesciences Limited₹1.19 L Cr₹1,188.126.74.4018.6%0.46+18.4%+22.3%
Lenskart Solutions Limited₹1.16 L Cr₹689.7181.413.305.6%0.35+35.4%—
Dr. Reddy's Laboratories Limited₹1.14 L Cr₹1,37440.63.0211.4%0.21+3.2%+14.5%
Cipla Limited₹1.13 L Cr₹1,40238.93.2711.3%0.02+2.1%-6.7%
Mankind Pharma Limited₹1.03 L Cr₹2,47545.96.3111.7%0.39+17.0%+3.1%
Aurobindo Pharma Limited₹98,101.93 Cr₹1,70526.62.599.2%0.21+6.4%+48.4%
Aster DM Quality Care Limited₹59,323.34 Cr₹719.55110.412.968.5%0.49+12.1%+4.5%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

ASTERDM

Aster DM Quality Care Invests INR 500 Cr in 300-Bed Hospital in Hyderabad

Digital Health News · 6 days ago

ASTERDM

Aster DM Quality Care Reports Record Q2 Revenue of ₹2,829 Crore

Multibagg AI · 9 days ago